Programmed Death-Ligand 1 as a Regulator of Tumor Progression and Metastasis

被引:19
作者
Vathiotis, Ioannis A. [1 ,2 ]
Gomatou, Georgia [1 ]
Stravopodis, Dimitrios J. [3 ]
Syrigos, Nikolaos [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Dept Med, Sch Med, Athens 15772, Greece
[2] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[3] Natl & Kapodistrian Univ Athens, Dept Biol, Sch Med, Athens 15772, Greece
关键词
PD-1; PD-L1; cancer; progression; metastasis; SQUAMOUS-CELL CARCINOMA; PD-L1; EXPRESSION; CLINICAL-SIGNIFICANCE; PROGNOSTIC-SIGNIFICANCE; MESENCHYMAL TRANSITION; ANTITUMOR IMMUNITY; CANCER EXOSOMES; LUNG-CANCER; CMTM6; HETEROGENEITY;
D O I
10.3390/ijms22105383
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) immune checkpoint has long been implicated in modeling antitumor immunity; PD-1/PD-L1 axis inhibitors exert their antitumor effects by relieving PD-L1-mediated suppression on tumor-infiltrating T lymphocytes. However, recent studies have unveiled a distinct, tumor-intrinsic, potential role for PD-L1. In this review, we focus on tumor-intrinsic PD-L1 signaling and delve into preclinical evidence linking PD-L1 protein expression with features of epithelial-to-mesenchymal transition program, cancer stemness and known oncogenic pathways. We further summarize data from studies supporting the prognostic significance of PD-L1 in different tumor types. We show that PD-L1 may indeed have oncogenic potential and act as a regulator of tumor progression and metastasis.
引用
收藏
页数:13
相关论文
共 107 条
[1]   Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes [J].
Agata, Y ;
Kawasaki, A ;
Nishimura, H ;
Ishida, Y ;
Tsubata, T ;
Yagita, H ;
Honjo, T .
INTERNATIONAL IMMUNOLOGY, 1996, 8 (05) :765-772
[2]   Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors [J].
Akbay, Esra A. ;
Koyama, Shohei ;
Carretero, Julian ;
Altabef, Abigail ;
Tchaicha, Jeremy H. ;
Christensen, Camilla L. ;
Mikse, Oliver R. ;
Cherniack, Andrew D. ;
Beauchamp, Ellen M. ;
Pugh, Trevor J. ;
Wilkerson, Matthew D. ;
Fecci, Peter E. ;
Butaney, Mohit ;
Reibel, Jacob B. ;
Soucheray, Margaret ;
Cohoon, Travis J. ;
Janne, Pasi A. ;
Meyerson, Matthew ;
Hayes, D. Neil ;
Shapiro, Geoffrey I. ;
Shimamura, Takeshi ;
Sholl, Lynette M. ;
Rodig, Scott J. ;
Freeman, Gordon J. ;
Hammerman, Peter S. ;
Dranoff, Glenn ;
Wong, Kwok-Kin .
CANCER DISCOVERY, 2013, 3 (12) :1355-1363
[3]   Self-renewal and solid tumor stem cells [J].
Al-Hajj, M ;
Clarke, MF .
ONCOGENE, 2004, 23 (43) :7274-7282
[4]   EpCAM (CD326) finding its role in cancer [J].
Baeuerle, P. A. ;
Gires, O. .
BRITISH JOURNAL OF CANCER, 2007, 96 (03) :417-423
[5]   Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer [J].
Barrett, Michael T. ;
Anderson, Karen S. ;
Lenkiewicz, Elizabeth ;
Andreozzi, Mariacarla ;
Cunliffe, Heather E. ;
Klassen, Christine L. ;
Dueck, Amylou C. ;
McCullough, Ann E. ;
Reddy, Srikanth K. ;
Ramanathan, Ramesh K. ;
Northfelt, Donald W. ;
Pockaj, Barbara A. .
ONCOTARGET, 2015, 6 (28) :26483-26493
[6]   Comprehensive molecular characterization of gastric adenocarcinoma [J].
Bass, Adam J. ;
Thorsson, Vesteinn ;
Shmulevich, Ilya ;
Reynolds, Sheila M. ;
Miller, Michael ;
Bernard, Brady ;
Hinoue, Toshinori ;
Laird, Peter W. ;
Curtis, Christina ;
Shen, Hui ;
Weisenberger, Daniel J. ;
Schultz, Nikolaus ;
Shen, Ronglai ;
Weinhold, Nils ;
Keiser, David P. ;
Bowlby, Reanne ;
Sipahimalani, Payal ;
Cherniack, Andrew D. ;
Getz, Gad ;
Liu, Yingchun ;
Noble, Michael S. ;
Pedamallu, Chandra ;
Sougnez, Carrie ;
Taylor-Weiner, Amaro ;
Akbani, Rehan ;
Lee, Ju-Seog ;
Liu, Wenbin ;
Mills, Gordon B. ;
Yang, Da ;
Zhang, Wei ;
Pantazi, Angeliki ;
Parfenov, Michael ;
Gulley, Margaret ;
Piazuelo, M. Blanca ;
Schneider, Barbara G. ;
Kim, Jihun ;
Boussioutas, Alex ;
Sheth, Margi ;
Demchok, John A. ;
Rabkin, Charles S. ;
Willis, Joseph E. ;
Ng, Sam ;
Garman, Katherine ;
Beer, David G. ;
Pennathur, Arjun ;
Raphael, Benjamin J. ;
Wu, Hsin-Ta ;
Odze, Robert ;
Kim, Hark K. ;
Bowen, Jay .
NATURE, 2014, 513 (7517) :202-209
[7]   Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape? [J].
Bruttel, Valentin S. ;
Wischhusen, Joerg .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[8]   CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity [J].
Burr, Marian L. ;
Sparbier, Christina E. ;
Chan, Yih-Chih ;
Williamson, James C. ;
Woods, Katherine ;
Beavis, Paul A. ;
Lam, Enid Y. N. ;
Henderson, Melissa A. ;
Bell, Charles C. ;
Stolzenburg, Sabine ;
Gilan, Omer ;
Bloor, Stuart ;
Noori, Tahereh ;
Morgens, David W. ;
Bassik, Michael C. ;
Neeson, Paul J. ;
Behren, Andreas ;
Darcy, Phillip K. ;
Dawson, Sarah-Jane ;
Voskoboinik, Ilia ;
Trapani, Joseph A. ;
Cebon, Jonathan ;
Lehner, Paul J. ;
Dawson, Mark A. .
NATURE, 2017, 549 (7670) :101-105
[9]   Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer [J].
Cao, Dalong ;
Qi, Zihao ;
Pang, Yangyang ;
Li, Haoran ;
Xie, Huyang ;
Wu, Junlong ;
Huang, Yongqiang ;
Zhu, Yao ;
Shen, Yijun ;
Zhu, Yiping ;
Dai, Bo ;
Hu, Xin ;
Ye, Dingwei ;
Wang, Ziliang .
CANCER RESEARCH, 2019, 79 (10) :2604-2618
[10]   Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response [J].
Chen, Gang ;
Huang, Alexander C. ;
Zhang, Wei ;
Zhang, Gao ;
Wu, Min ;
Xu, Wei ;
Yu, Zili ;
Yang, Jiegang ;
Wang, Beike ;
Sun, Honghong ;
Xia, Houfu ;
Man, Qiwen ;
Zhong, Wenqun ;
Antelo, Leonardo F. ;
Wu, Bin ;
Xiong, Xuepeng ;
Liu, Xiaoming ;
Guan, Lei ;
Li, Ting ;
Liu, Shujing ;
Yang, Ruifeng ;
Lu, Youtao ;
Dong, Liyun ;
McGettigan, Suzanne ;
Somasundaram, Rajasekharan ;
Radhakrishnan, Ravi ;
Mills, Gordon ;
Lu, Yiling ;
Kim, Junhyong ;
Chen, Youhai H. ;
Dong, Haidong ;
Zhao, Yifang ;
Karakousis, Giorgos C. ;
Mitchell, Tara C. ;
Schuchter, Lynn M. ;
Herlyn, Meenhard ;
Wherry, E. John ;
Xu, Xiaowei ;
Guo, Wei .
NATURE, 2018, 560 (7718) :382-+